These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 34478821)

  • 1. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
    Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
    Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating level of sPD-1 and PD-1 genetic variants are associated with hepatitis B infection and related liver disease progression.
    Huyen PTM; Dung DTN; Weiß PJ; Hoan PQ; Giang DP; Uyen NT; Van Tuan N; Trung NT; Velavan TP; Song LH; Hoan NX
    Int J Infect Dis; 2022 Feb; 115():229-236. PubMed ID: 34910956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection.
    Sy BT; Hoan NX; Tong HV; Meyer CG; Toan NL; Song LH; Bock CT; Velavan TP
    World J Gastroenterol; 2018 Jan; 24(2):248-256. PubMed ID: 29375210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
    Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
    Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression.
    Hoan NX; Huyen PTM; Binh MT; Trung NT; Giang DP; Linh BT; Dung DTN; Pallerla SR; Kremsner PG; Velavan TP; Bang MH; Song LH
    Sci Rep; 2021 Apr; 11(1):7772. PubMed ID: 33833369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
    Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients.
    Hassan M; Attia MS; Ali-Eldin Z; El Attar G; Elzallat M; Saad HHK; Isaac A
    Tumour Virus Res; 2022 Dec; 14():200249. PubMed ID: 36265835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus.
    Hoan NX; Khuyen N; Giang DP; Binh MT; Toan NL; Anh DT; Trung NT; Bang MH; Meyer CG; Velavan TP; Song LH
    BMC Med Genet; 2019 Dec; 20(1):201. PubMed ID: 31864292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between TNFR gene polymorphisms and the risk of Hepatitis B Virus-Related Liver Diseases in Chinese population.
    Ma L; Chen S; Mao X; Lu Y; Zhang X; Lao X; Qin X; Li S
    Sci Rep; 2018 Jun; 8(1):9240. PubMed ID: 29915336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1 mRNA expression is associated with clinical and viral profile and PD1 3'-untranslated region polymorphism in patients with chronic HBV infection.
    Zhang G; Li N; Zhang P; Li F; Yang C; Zhu Q; Han Q; Lv Y; Zhou Z; Liu Z
    Immunol Lett; 2014 Nov; 162(1 Pt A):212-6. PubMed ID: 25218665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits.
    Li Z; Liu Z; Zhang G; Han Q; Li N; Zhu Q; Lv Y; Chen J; Xing F; Wang Y; Li F
    Tissue Antigens; 2012 Aug; 80(2):151-7. PubMed ID: 22587604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
    Hu HH; Liu J; Lin YL; Luo WS; Chu YJ; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; You SL; Yang HI; Chen CJ;
    Gut; 2016 Sep; 65(9):1514-21. PubMed ID: 26642861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of ESR2 Gene Polymorphisms on Susceptibility to Hepatitis B Virus-Related Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma.
    Jie Z; Hongkun J; Shi Y; Fengxun Y; Xin L; Yijun M; Yu L
    Biochem Genet; 2024 Oct; 62(5):3946-3960. PubMed ID: 38245888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14
    Huang ZY; Xu P; Li JH; Zeng CH; Song HF; Chen H; Zhu YB; Song YY; Lu HL; Shen CP; Zhang XG; Wu MY; Wang XF
    Viral Immunol; 2017 Apr; 30(3):224-231. PubMed ID: 28005469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population.
    Xie Q; Chen Z; Xia L; Zhao Q; Yu H; Yang Z
    Gene; 2018 Oct; 674():188-194. PubMed ID: 29940275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection.
    Li N; Zhou Z; Li F; Sang J; Han Q; Lv Y; Zhao W; Li C; Liu Z
    Oncotarget; 2017 Jul; 8(28):46020-46033. PubMed ID: 28545019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes.
    Song XM; Li QL; Guo F; Peng H; Guo JJ
    Ann Hepatol; 2018 Oct; 17(6):940-947. PubMed ID: 30600290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma.
    Cheng HY; Kang PJ; Chuang YH; Wang YH; Jan MC; Wu CF; Lin CL; Liu CJ; Liaw YF; Lin SM; Chen PJ; Lee SD; Yu MW
    PLoS One; 2014; 9(11):e95870. PubMed ID: 25427199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.